Certain cancer types, such as colorectal cancer (CRC), hepatocellular carcinoma, and lung cancer, are able to circumvent the cytostatic and apoptotic effects of TGFβ by mutating key players in its signaling cascade, allowing the transformed cells to undergo unrestrained growth3,4,7,8. Here, TGFB1 is linked to colorectal carcinoma.